Results 151 to 160 of about 24,027 (216)
Objective To verify the pathogenesis of the opioid growth factor receptor like‐1 (OGFRL1) loss‐of‐function variant (c.30del, p. F10Ffs*110) identified in a patient with chronic recurrent multifocal osteomyelitis (CRMO) and to investigate the underlying mechanism.
Wen Xiong +9 more
wiley +1 more source
Bullous Rheumatoid Neutrophilic Dermatosis-A Systematic Review of 28 Cases. [PDF]
Mazur E +4 more
europepmc +1 more source
An Unexpected Culprit: Allergic Contact Dermatitis Caused by Benzyl Alcohol in Moist Toilet Paper
Contact Dermatitis, Volume 95, Issue 1, Page 113-115, July 2026.
Lucía Martínez Rozas +3 more
wiley +1 more source
ABSTRACT We report a case of a 17‐year‐old girl diagnosed with several severe dermatological conditions: atopic dermatitis (AD), inverse and scalp psoriasis, pustular acne, and hidradenitis suppurativa (HS). We consider this case of particular interest because it is therapeutically challenging and because of its psychological impact on the patient's ...
Emanuele Amore +4 more
wiley +1 more source
International Journal of Dermatology, Volume 65, Issue 7, Page 1477-1479, July 2026.
Samantha Bestavros +2 more
wiley +1 more source
ABSTRACT Persistent facial lesions with benign superficial histopathology should prompt suspicion of deeper vascular anomalies. Clinicopathological discordance warrants early vascular imaging, as superficial biopsy may fail to detect underlying arteriovenous malformations, leading to delayed diagnosis and inappropriate management.
Qazi Syed Irfanullah Shah +3 more
wiley +1 more source
A Rapidly Progressive Bullous Eruption in a Toddler. [PDF]
Khalid A, Ghouri S, Proano JS.
europepmc +1 more source
Effective Management of Recalcitrant Hailey–Hailey Disease With Risankizumab
International Journal of Dermatology, Volume 65, Issue 7, Page 1457-1459, July 2026.
Joy Justice +3 more
wiley +1 more source
ABSTRACT Methotrexate (MTX) is a folate antagonist widely used as a disease‐modifying antirheumatic drug (DMARD) in rheumatoid arthritis (RA), as well as in several malignancies and autoimmune disorders. Although low‐dose MTX (5–20 mg/week) is generally considered safe, it has a narrow therapeutic index, and toxicity can occur even at therapeutic doses,
Fatemeh Afra +7 more
wiley +1 more source
Refractory linear IgA dermatosis in childhood: a successful response to rituximab. [PDF]
Wakisaka PS +5 more
europepmc +1 more source

